LONDON (Alliance News) - Akers Biosciences Inc said Tuesday it is launching its BreathScan OxiChek and BreathScan KetoCheck tests this week at the Supply Side West conference in Las Vegas, Nevada.
OxiChek tests for the level of oxidative stress in the body, which is implicated in diseases including cardiac, cancer and arthritic diseases. KetoChek is used to determine whether the body is in the fat-burning state known as ketosis, and can be used for weight loss purposes.
The two tests will work with bluetooth-enabled reading device BreathScan Lync and an associated mobile application.
"We believe that consumers are increasingly looking for personalized health, and that the BreathScan platform will provide the footprint for the company to enter into the new era of digital medicine. Our new health and wellness products are poised to make an impact now as we commence production and will begin shipping this quarter," said Co-Founder and Executive Chairman Raymond Akers Jr in a statement.
Akers Biosciences shares were untraded Tuesday at 175.00 pence.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
